Do you have Vitiligo ?
Would you consider participating in a clinical research study of an investigational therapy known as afamelanotide?
Eligible patients will receive either narrowband UVB (NB-UVB) light therapy in combination with afamelanotide, or with NB-UVB alone.
If You :
- Have vitiligo on your face and body
- Have a medium to dark skin type
- Are aged 12+
- Are able to attend up to 14 clinic visits over 12 months.
Then you may be eligible to participate, and partcipants may be eligible for travel reimbursements.



